Detalhe da pesquisa
1.
Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.
J Am Soc Nephrol
; 34(9): 1561-1573, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37303085